CD4 and infection: The 1.3 log10 lower viral set point in HLA-B*58:02–positive vaccinees and the inability of >50% to meet the CD4+ T-cell count criteria for ART initiation by 600 days after infection are consistent with vaccine-mediated protection against rapid progression.